14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 27895797 | UGT1A1*6, UGT1A7*3 and UGT1A9*1b polymorphisms are predictive markers for severe toxicity in patients with metastatic gastrointestinal cancer treated with irinotecan-based regimens. | 2016 Nov | 1 |
2 | 24834123 | Polymorphisms of uridine glucuronosyltransferase gene and irinotecan toxicity: low dose does not protect from toxicity. | 2014 | 1 |
3 | 23303296 | Polymorphisms of the UDP-glucuronosyl transferase 1A genes are associated with adverse events in cancer patients receiving irinotecan-based chemotherapy. | 2013 Feb | 1 |
4 | 23789755 | [Influence of genetic polymorphisms in UGT1A1, UGT1A7 and UGT1A9 on the pharmacokynetics of irinotecan, SN-38 and SN-38G]. | 2013 Mar-Apr | 5 |
5 | 24033692 | UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan. | 2013 Dec | 1 |
6 | 18349289 | Gilbert's Syndrome and irinotecan toxicity: combination with UDP-glucuronosyltransferase 1A7 variants increases risk. | 2008 Mar | 9 |
7 | 18418374 | Pharmacogenetic pathway analysis of irinotecan. | 2008 Sep | 6 |
8 | 17406868 | Genetic linkage of UGT1A7 and UGT1A9 polymorphisms to UGT1A1*6 is associated with reduced activity for SN-38 in Japanese patients with cancer. | 2007 Sep | 3 |
9 | 15709193 | UGT1A7 and UGT1A9 polymorphisms predict response and toxicity in colorectal cancer patients treated with capecitabine/irinotecan. | 2005 Feb 1 | 2 |
10 | 15716465 | Identification and characterization of a functional TATA box polymorphism of the UDP glucuronosyltransferase 1A7 gene. | 2005 May | 2 |
11 | 12730278 | Functional characterization of human UDP-glucuronosyltransferase 1A9 variant, D256N, found in Japanese cancer patients. | 2003 Aug | 2 |
12 | 12036456 | Genetic polymorphisms of the UDP-glucuronosyltransferase 1A7 gene and irinotecan toxicity in Japanese cancer patients. | 2002 May | 1 |
13 | 12181437 | Common human UGT1A polymorphisms and the altered metabolism of irinotecan active metabolite 7-ethyl-10-hydroxycamptothecin (SN-38). | 2002 Sep | 1 |
14 | 10381366 | Glucuronidation of 7-ethyl-10-hydroxycamptothecin (SN-38) by the human UDP-glucuronosyltransferases encoded at the UGT1 locus. | 1999 Jun 24 | 1 |